Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer

SIMPLE SUMMARY: The prognosis of non-small cell lung cancer (NSCLC) is poor as more than half of the patients are diagnosed at an advanced stage. The outcomes have greatly improved in the recent two decades due to the introduction of target therapy. Anaplastic lymphoma kinase (ALK) rearrangement is...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: Chuang, Cheng-Hao, Chen, Hsiao-Ling, Chang, Hsiu-Mei, Tsai, Yu-Chen, Wu, Kuan-Li, Chen, I-Hua, Chen, Kung-Chao, Lee, Jui-Ying, Chang, Yong-Chieh, Chen, Chin-Ling, Tu, Yu-Kang, Hung, Jen-Yu, Yang, Chih-Jen, Chong, Inn-Wen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2021
Gaiak:
Systematic Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8072703/
https://ncbi.nlm.nih.gov/pubmed/33921762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13081966
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak